In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
Uttarakhand Election 2022 Union Home Minister Amit Shah, who visited Uttarakhand, challenged the
New 5G Smartphone: If you are a fan of the Realme phone, then there is good news for you. Soon th
Tensions between India and Bangladesh have taken a new turn. The controversy escalated after Must
COVID-19: China's warning - Corona cases may increase again this month, claims in the report
Corona cases have been comparatively less in China since the New Year, but now the Chinese govern
Lakhs of devotees are heading towards Sangam city Prayagraj on the occasion of Mauni Amavasya. Bu
Bigg Boss OTT 2 Winner Elvish Yadav On Bollywood: The controversial reality show 'Bigg Boss OTT S
Time 2 pm. Everywhere in Pikaura village of Mankapur, there was a discussion about the train acci
Kisan Andolan News All the three anti-agricultural law agitators are beginning to understand that
The level of pollution in the country's capital Delhi is continuously increasing. Delhi Environme
5G Smartphone: Budget smartphone maker Techno has launched its first 5G smartphone in India. This
